M R7 (Rabeprazole Sodium Delayed-Release 20 mg)
Pill with imprint M R7 is Beige, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Mylan Pharmaceuticals Inc..
Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M R7
Related Images for "M R7"
More about rabeprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 71 Reviews
- Drug class: proton pump inhibitors
- FDA Alerts (3)
- Patient Information
- Rabeprazole (Advanced Reading)
- Rabeprazole Delayed-Release Tablets
- Rabeprazole Sprinkle Capsules
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.